BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 28, 2020
View Archived Issues
Targeting GCGR signaling pathway counteracts PI3K inhibitor-induced hyperglycemia
Read More
DISC-0974 decreases hepcidin and increases transferrin saturation in inflammation models
Read More
First-in-human data presented for talquetamab in patients with RRMM
Read More
Results of RCT evaluating nilotinib in patients with moderately advanced Parkinson's disease
Read More
DISC-A demonstrates efficacy in low hepcidin rat model
Read More
CTPS2 as novel prognostic biomarker in CLL
Read More
FDA lifts clinical hold on ASPIRO study of AT-132
Read More
Orelabrutinib approved in China for two cancer indications
Read More
Shanghai Institute of Materia Medica, Fudan University patent PD-1/PD-L1 interaction inhibitors
Read More
First subject dosed in phase I study of ASC-42
Read More
National Institute of Pharmaceutical R&D describes M3 antagonists/beta2-adrenoceptor agonists
Read More
New autotaxin inhibitors described by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical
Read More
Medshine Discovery synthesizes new JAK1/JAK2 inhibitors
Read More
New ERK inhibitors discovered at Hutchison MediPharma
Read More
Byvasda approved in China the treatment of recurrent glioblastoma
Read More
Arctic Vision obtains IND approval for ARVN-001 in China
Read More
NX-2127 shows promising antitumor activity in models of B-cell malignancies
Read More
Enrollment ongoing in phase II study of PHA-022121
Read More
Nociceptive neurons shown to boost hematopoiesis
Read More
Geron initiates phase III study of imetelstat in myelofibrosis refractory to JAK inhibitors
Read More
ZyCoV-D vaccine candidate demonstrates safety and immunogenicity in phase I/II study
Read More
Primary endpoint not met in phase III trial of eprenetapopt in TP53-mutant myelodysplastic syndromes
Read More
